Inventor
ADAM SHULTZ ADLER
Inventor
US
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides21%
C12NMicroorganisms or enzymes17%
C40BCombinatorial chemistry17%
A61KPreparations for medical, dental or toiletry purposes15%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
Y02ATechnologies for adaptation to climate change9%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
PatentTitleYear
12,590,386Recombinant polyclonal proteins and methods of use thereof202612,497,711Engineered cells expressing anti-viral T cell receptors and methods of use thereof202512,421,311Anti-CTLA-4 binding proteins and methods of use thereof202512,404,607Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof202512,195,880Systems and methods for massively parallel combinatorial analysis of single cells202511,718,660Recombinant polyclonal proteins targeting Zika and methods of use thereof202311,685,779Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof202311,441,240Systems and methods for massively parallel combinatorial analysis of single cells202211,427,933Systems and methods for massively parallel combinatorial analysis of single cells202211,421,220Engineered cells expressing anti-viral T cell receptors and methods of use thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to GIGAGEN INC (8)· patent assignee history
2022–2025Patents assigned to GIGAMUNE INC (2)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GIGAGEN INC | 8 | 2022–2026 |
| GIGAMUNE INC | 2 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 10 | 2022–2026 |